{ }
Worldcoin, now rebranded as "World," faces EU demands to delete iris-scanning data by January 19, 2025, due to privacy violations under GDPR. The initiative, aimed at reducing identity fraud through biometric data, has sparked significant regulatory scrutiny and concerns over user consent and data security. Despite the challenges, the company maintains its vision for a digital identity network, while its native token, WLD, has seen a notable increase in value.
The Food for Special Medical Purpose market is poised for growth, driven by the rise in chronic illnesses and an aging population, particularly in Asia Pacific and Europe. Key players include Nestle, Danone Nutricia, and Abbott, with significant investments in R&D despite high costs and regulatory challenges. The market focuses on tailored nutritional solutions for infants, adults, and the elderly, reflecting evolving dietary needs.
The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
The Global Fermented Beverages market, valued at 860 billion USD in 2024, is projected to reach 1.3 trillion USD by 2032, growing at a CAGR of 6.4%. The market analysis covers major regions including North America, Europe, and Asia-Pacific, with customization options available for specific countries and applications. Key players include Apple, Microsoft, and Nestlé, with insights into market dynamics, competitive landscape, and growth drivers such as lifestyle changes and technological advancements in fermentation.
The global Seasoning Market is poised for significant growth from 2024 to 2031, driven by key players like McCormick & Company and Nestle. The market analysis includes trends, dynamics, and opportunities, with a focus on regional contributions and competitive strategies among major manufacturers. Comprehensive insights into market segmentation and the impact of various factors on demand are also provided, aiding stakeholders in making informed business decisions.
Europol, in collaboration with law enforcement from six countries, dismantled an international drug trafficking ring, seizing $26 million in cryptocurrencies and other valuables. The operation, linked to cocaine trafficking, highlighted Bitcoin's continued use among criminals, despite the rise of privacy coins. Authorities emphasized the potential of blockchain technology to aid in combating organized crime, while challenges remain due to the anonymity of crypto transactions.
Pernod Ricard, the leading global producer of premium spirits and wines, reported net sales with 61.8% from strategic international brands, including Absolut and Jameson. Local brands account for 18.2%, craft spirits 7.3%, and strategic wines 3.6%. The company operates 94 production sites worldwide, with sales distributed across Europe (28.3%), the Americas (28.8%), and other regions (42.9%).
In 2024, global IPO activity declined, with a 10% drop in the number of offerings to 1,215 and a 4% decrease in transaction value to $121 billion. The U.S. market saw significant growth, while China experienced a dramatic slump, with IPOs halving to 170 and transaction value plummeting by 65%. Despite challenges, optimism for a revival in capital markets is noted, particularly in Switzerland, driven by interest rate cuts and favorable market conditions.
In 2024, global IPO activity declined, with a 10% drop in the number of offerings to 1,215 and a 4% decrease in transaction value to $121 billion. The US market saw significant growth, while China's IPOs plummeted by over half, reflecting stark regional disparities influenced by deglobalization and interest rate changes. Switzerland's Galderma IPO ranked fifth globally, and experts express optimism for a market revival in 2025, driven by favorable conditions and potential deregulation in the US.
The global gene therapy market, valued at $7.54 billion in 2022, is projected to reach $41.38 billion by 2031, driven by increased R&D, favorable regulations, and collaborations between pharmaceutical companies and academic institutions. North America leads the market, with significant advancements in biotechnology and numerous clinical trials. Recent developments include Novartis's acquisition of a gene therapy candidate from Avrobio and Bristol-Myers Squibb's expansion of its cell therapy manufacturing network.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.